Suchergebnisse

Dolby Laboratories, Inc. DLB expects a sharp fiscal fourth-quarter rebound after third-quarter revenues fell 3.3% year over year to $305 million. The guidance midpoint points to approximately 23%

Dolby Laboratories, Inc. DLB offers exposure to wider adoption of premium audio and imaging, automotive licensing and content-platform monetization. Its discounted valuation and substantial cash

AbbVie Inc. ABBV paired strong product momentum with a more complex 2026 outlook. Management raised revenue expectations, while the planned Apogee Therapeutics acquisition pushed adjusted earnings

We expect Outlook Therapeutics OTLK to beat expectations when it reports third-quarter fiscal 2026 results later this month. In the last reported quarter, the company delivered a negative earnings

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. However, when you're an income investor, your

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from

Investors in Alexandria Real Estate Equities, Inc. ARE need to pay close attention to the stock based on moves in the options market lately. That is because the October 20, 2026 $77.50 Call had some

Microsoft Corporation's MSFT fourth-quarter fiscal 2026 earnings have brought back investor enthusiasm for artificial intelligence (AI), cloud computing and mega-cap technology. The software giant

EMCOR Group, Inc. EME is producing faster earnings growth, record contracted work and a higher full-year outlook. Those strengths support the case for buying the stock despite its recent

BorgWarner Inc. BWA is slated to release second-quarter 2026 results on Aug. 5, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings per share (EPS) and

Ingredion Incorporated INGR trades at a sizable discount, while its higher-value specialty portfolio continues to improve. That combination creates a credible value case.The obstacle is execution

EMCOR Group, Inc. EME entered the second half of 2026 with record remaining performance obligations and a sharply higher outlook. The combination could extend its earnings momentum if contracted

ADP ADP enters fiscal 2027 with steady revenue growth, wider margins and dependable shareholder distributions. Management's outlook indicates that earnings can continue rising faster than sales.

The